dilantin paediatric
viatris limited - phenytoin 6 mg/ml - oral suspension - 30 mg/5ml - active: phenytoin 6 mg/ml excipient: aluminium magnesium silicate carmellose sodium carmoisine citric acid monohydrate ethanol imitation banana flavour 510120e glycerol polysorbate 40 purified water sodium benzoate sucrose sunset yellow fcf terpeneless orange oil vanillin
konakion mm paediatric
pharmaco (nz) ltd - phytomenadione 10 mg/ml - solution for injection - 10 mg/ml - active: phytomenadione 10 mg/ml excipient: glycocholic acid hydrochloric acid lecithin sodium hydroxide water for injection
lanoxin paediatric
pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.05 mg/ml; - elixir - 0.05 mg/ml - active: digoxin 0.05 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate ethanol lime flavour 70.80.0303 methyl hydroxybenzoate propylene glycol purified water quinoline yellow sucrose - lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation.
konakion mm paediatric 2 mg0.2 ml
tzamal bio-pharma ltd - phytomenadione - solution for injection - phytomenadione 10 mg/ml - phytomenadione - phytomenadione - prophylaxis and treatment of haemorrhoagic disease of the newborn.
klacid paediatric suspension 125 mg5 ml
abbott medical laboratories ltd, israel - clarithromycin - granules for reconstitution - clarithromycin 125 mg / 5 ml - clarithromycin - clarithromycin - bronchitis, pharyngitis, tonsilitis pneumonia skin infections due to susceptible microorganisms. treatment of mycobacterium avium complex in patients with aids. treatment of otitis media.
malarone paediatric tablets
glaxo smith kline (israel) ltd - atovaquone; proguanil hydrochloride - film coated tablets - atovaquone 62.5 mg; proguanil hydrochloride 25 mg - proguanil, combinations - proguanil, combinations - "- prevention of malaria:for the prophylaxis of p.falciparum malaria, including in areas where chloroquine resistance has been reported.- treatment of malaria: for the treatment of acute, uncomplicated p.flaciparum malaria.malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.
amoxil paediatric 125 mg/1.25 ml powder for oral suspension
glaxosmithkline (ireland) limited - amoxicillin - powder for oral suspension - 125 mg/1.25 millilitre(s) - penicillins with extended spectrum; amoxicillin
augmentin paediatric 125 mg/31.25 mg per 5 ml powder for oral suspension
glaxosmithkline (ireland) limited - amoxicillin; clavulanic acid - powder for oral suspension - 125 mg/31.25 mg/5ml - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor
brufen paediatric 100 mg/5ml oral suspension
abbott laboratories ireland ltd - ibuprofen - oral suspension - 100 mg/5ml
cidomycin paediatric 20mg/2ml solution for injection
sanofi-aventis ireland limited t/a sanofi - gentamicin sulfate - solution for injection - 20 mg/2ml - other aminoglycosides; gentamicin